Life Sciences Breakfast Briefing
Evolving tendering and pricing landscape: Impact on ROI for pharmaceutical and medical device companies
Pharmaceutical and medical device industries continue to face downward pressures on prices and overall margins through the widespread use of cost-containment strategies. Moreover, payers are increasingly focused on formal procedures, such as tendering, to procure drugs and medical devices to further reduce the cost per patient for in-market and mature drugs and technologies. More than ever, it has become critical to analyse and understand the drivers that are shaping ROI in European markets.
Please join IHS Markit experts on 24 October in Paris, France for the Life Sciences Breakfast Briefing, where they will address the following topics:
- Evolving dynamics in pricing trends in Europe
- A European perspective on tendering for pharmaceuticals and medical devices
- Tendering and pricing in Italy